Results 11 to 20 of about 121,985 (386)

Perceived barriers to methadone maintenance treatment among Iranian opioid users

International Journal for Equity in Health, 2018
Background Opioid use is a severe problem in Iran. Despite methadone maintenance treatment (MMT) programs being one of the most important treatment strategies for reducing individual and public harms associated with opioid use, a large proportion of ...
Maryam Khazaee-Pool, Maryam Moeeni, Koen Ponnet, Arezoo Fallahi, Leila Jahangiri, Tahereh Pashaei   +5 more
doaj   +2 more sources

Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy.

New England Journal of Medicine, 2022
BACKGROUND Opioid agonist therapy is strongly recommended for pregnant persons with opioid use disorder. Buprenorphine may be associated with more favorable neonatal and maternal outcomes than methadone, but existing data are limited.
Elizabeth A. Suarez, K. Huybrechts, L. Straub, S. Hernández-Díaz, H. Jones, H. Connery, J. Davis, K. Gray, B. Lester, M. Terplan, H. Mogun, B. Bateman   +11 more
semanticscholar   +1 more source

Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs.

JAMA psychiatry, 2022
Presents a study which aims to examine methadone-involved overdose deaths before and after federal policy in US. US Centers for Disease Control and Prevention National Vital Statistics System multiple cause of death 2019- 2020 final and 2021 provisional ...
Christopher M. Jones, W. Compton, B. Han, Grant Baldwin, N. Volkow   +4 more
semanticscholar   +1 more source

Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada

JAMA Network Open, 2021
Key Points Question How does timely methadone access for opioid use disorder compare between the US and Canada during COVID-19? Findings In this cross-sectional study of methadone clinics during COVID-19 in 13 US states and the District of Columbia and 3
P. J. Joudrey, Zoe M. Adams, P. Bach, Sarah Van Buren, Jessica A. Chaiton, Lucy Ehrenfeld, M. Guerra, Brynna Gleeson, S. Kimmel, Ashley Medley, Wassim Mekideche, Maxime Paquet, Minhee Sung, Melinda Wang, R. O. O. You Kheang, Jingxian Zhang, E. Wang, E. J. Edelman   +17 more
semanticscholar   +1 more source

Perioperative Methadone and Ketamine for Postoperative Pain Control in Spinal Surgical Patients: A Randomized, Double-blind, Placebo-controlled Trial

Anesthesiology, 2021
Background: Despite application of multimodal pain management strategies, patients undergoing spinal fusion surgery frequently report severe postoperative pain.
G. Murphy, M. Avram, S. Greenberg, J. Benson, S. Bilimoria, Colleen E Maher, Kevin J Teister, J. Szokol   +7 more
semanticscholar   +1 more source

Survival, safety and belonging: An ethnographic study of experiences and perceptions of people who inject drugs accessing a supervised injecting Centre

Australian Journal of Social Issues, Volume 57, Issue 4, Page 829-846, December 2022., 2022
Abstract Introduction The inclusion of people who use drugs in the design and evaluation of their health services remains a relatively new phenomenon. The aim of the research was to explore the experiences and perceptions of people accessing the Medical Supervised Injecting Centre (MSIC), and Clinic 180, Sydney Australia, and the factors facilitating ...
Greg Rickard, Bethne Hart
wiley   +1 more source

Methadone is methadone

Canadian Family Physician, 2021
As a pharmacist who has been dispensing methadone for more than 20 years to patients in and out of Ontario provincial jails, I read the article by Raski et al in the November issue[1][1] with interest (and gratitude to one of the doctors on our team, who thoughtfully clipped this article out of ...
openaire   +3 more sources

Methadone for Opioid Use Disorder-Decades of Effectiveness but Still Miles Away in the US.

JAMA psychiatry, 2020
In 1974, President Nixon signed the Narcotic Addiction Treatment Act, which gave statutory authority to the regulations governing the provision of methadone for the treatment of opioid use disorder (OUD) in the US.
P. J. Joudrey, E. J. Edelman, E. Wang
semanticscholar   +1 more source

Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry

bioRxiv, 2020
Despite the rising prevalence of methadone treatment in pregnant women with opioid use disorder, the effects of methadone on neurobehavioral development remain unclear.
Gregory G. Grecco, Briana E Mork, Jui-Yen Huang, Corinne E. Metzger, D. Haggerty, Kaitlin C. Reeves, Yong Gao, Hunter Hoffman, S. Katner, A. Masters, Cameron W. Morris, Erin A Newell, E. Engleman, A. Baucum, Jieun Kim, B. Yamamoto, M. Allen, Yu-chien Wu, Hui-Chen Lu, Patrick L. Sheets, Brady K. Atwood   +20 more
semanticscholar   +1 more source

Retention in treatment and therapeutic adherence: How are these associated with therapeutic success? An analysis using real‐world data

International Journal of Methods in Psychiatric Research, Volume 31, Issue 4, December 2022., 2022
Abstract Introduction Treatment retention and adherence are used as outcomes in numerous randomized clinical trials and observational studies conducted in the addiction field. Although usual criteria are 3/6 months of treatment retention or number of sessions attended, there is not a methodological support for conclusions using these criteria.
Daniel Dacosta‐Sánchez, Bella M. González‐Ponce, Fermín Fernández‐Calderón, Manuel Sánchez‐García, Oscar M. Lozano   +4 more
wiley   +1 more source